Fresenius Kabi announces two deals to bolster position in biosimilars and medtech
Fresenius Kabi purchased a majority stake in mAbxience; and acquired the specialised infusion therapy company Ivenix
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Apr 22
Fresenius Kabi purchased a majority stake in mAbxience; and acquired the specialised infusion therapy company Ivenix
31 Mar 22
The device will enhance patient access and communication between patients and ophthalmologists, collect data, and serve as a…
28 Mar 22
AviClear is the First Device Cleared for the Treatment of Mild, Moderate and Severe Acne, that has been…
18 Mar 22
Physicians at the Clinica Porto Azul in Barranquilla, Colombia have successfully completed the implantation of the PortIO intraosseous…
04 Feb 22
The company intends to use the financing to support the expansion and commercialisation of its Dayspring active compression…
03 Feb 22
The device facilitated the safe transport of donor lungs for a record distance of about 7,705km with a…
31 Jan 22
Plasma IQ is the first FDA approved handheld plasma energy device indicated for the removal and destruction of…
24 Jan 22
Dermapen revolutionized the aesthetic industry a decade ago by inventing the first ever automated microneedling pen—the original and…
13 Jan 22
Suneva's product portfolio consists of minimally invasive solutions, including products that use the body’s restorative capacity in non-surgical…
13 Dec 21
The five-year contract, effective December 15, 2021 through December 14, 2026, allows federal customers to efficiently purchase advanced,…